Rapid mutation screening in type 2A von Willebrand's disease using universal heteroduplex generators

被引:8
作者
Culpan, D
Standen, G
Wood, N
Mazurier, C
Gaucher, C
Bidwell, J
机构
[1] BRISTOL ROYAL INFIRM & GEN HOSP,DEPT HAEMATOL,MOL HAEMATOL UNIT,BRISTOL BS2 8HW,AVON,ENGLAND
[2] UNIV BRISTOL,DEPT TRANSPLANTAT SCI,BRISTOL,AVON,ENGLAND
[3] LFB,LAB RECH HEMOSTASE,LILLE,FRANCE
关键词
von Willebrand's disease type 2A; mutation; heteroduplex; genotype;
D O I
10.1046/j.1365-2141.1997.d01-2054.x
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Patients with type 2A von Willebrand's disease (VWD) commonly have missense mutations in the A2 domain of the von Willebrand factor (VWF) protein. This domain is encoded by the 3' region of VWF gene exon 28 and the large majority of patients have heterozygous mutations clustered in the sequence between codons 742 and 909. We describe a DNA-based diagnostic technique which enables at least 10 previously described mutations to be rapidly identified. The method involves polymerase chain reaction (PCR) amplification of two exon 28 gene segments between codons 717-788 and 803-893, respectively. Each fragment is then hybridized with a synthetic complementary DNA molecule of similar size, termed a Universal Heteroduplex Generator (UHG). The UHG contains base deletions contiguous to the sites of known mutations and, following hybridization, allele-specific heteroduplexes are generated which can be detected by simple polyacrylamide gel electrophoresis and ethidium bromide staining. A small panel of UHG molecules covering the 3' region of exon 28 should enable the large majority of type 2A VWD patients to be rapidly diagnosed by genotype.
引用
收藏
页码:464 / 469
页数:6
相关论文
共 18 条
[1]  
BIDWELL J, 1994, AD ELECTROP, V7, P311
[2]  
BIDWELL JL, 1993, HDB HLA TYPING TECHN
[3]   Analysis of Arg834Gln and Va1902Glu type 2A von Willebrand disease mutations. Studies with recombinant von Willebrand factor and correlation with patient characteristics [J].
Englender, T ;
Lattuada, A ;
Mannucci, PM ;
Sadler, JE ;
Inbal, A .
BLOOD, 1996, 87 (07) :2788-2794
[4]  
GAUCHER C, 1995, THROMB HAEMOSTASIS, V73, P610
[5]  
GINSBURG D, 1993, THROMB HAEMOSTASIS, V69, P177
[6]  
GINSBURG D, 1992, BLOOD, V79, P2507
[7]   IDENTIFICATION OF 3 CANDIDATE MUTATIONS CAUSING TYPE-IIA VON-WILLEBRAND DISEASE USING A RAPID, NONRADIOACTIVE, ALLELE-SPECIFIC HYBRIDIZATION METHOD [J].
INBAL, A ;
ENGLENDER, T ;
KORNBROT, N ;
RANDI, AM ;
CASTAMAN, G ;
MANNUCCI, PM ;
SADLER, JE .
BLOOD, 1993, 82 (03) :830-836
[8]  
LYONS SE, 1992, J BIOL CHEM, V267, P4424
[9]   HUMAN VONWILLEBRAND-FACTOR GENE AND PSEUDOGENE - STRUCTURAL-ANALYSIS AND DIFFERENTIATION BY POLYMERASE CHAIN-REACTION [J].
MANCUSO, DJ ;
TULEY, EA ;
WESTFIELD, LA ;
LESTERMANCUSO, TL ;
LEBEAU, MM ;
SORACE, JM ;
SADLER, JE .
BIOCHEMISTRY, 1991, 30 (01) :253-269
[10]  
RIBBA AS, 1994, BLOOD, V83, P833